Acadia Pharmaceuticals (ACAD) Goodwill & Intangibles (2016 - 2026)

Acadia Pharmaceuticals' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $106.2 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 9.3% year-over-year to $106.2 million; the TTM figure through Mar 2026 stood at $106.2 million (down 9.3% YoY), while the FY2025 annual figure was $108.9 million, down 9.09% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $106.2 million, down from $108.9 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $119.8 million in Q4 2024, with the low at $65.5 million in Q4 2023.
• The 4-year median for Goodwill & Intangibles is $107.9 million (2024), against an average of $98.5 million.
• The sharpest annual moves came in 2024 and 2026: Goodwill & Intangibles jumped 82.9% in 2024, then decreased 9.3% in 2026.
• Acadia Pharmaceuticals' Goodwill & Intangibles stood at $65.5 million in 2023, then soared by 82.9% to $119.8 million in 2024, then declined by 9.09% to $108.9 million in 2025, then fell by 2.5% to $106.2 million in 2026.
• Business Quant data shows ACAD's Goodwill & Intangibles at $106.2 million in Q1 2026, $108.9 million in Q4 2025, and $111.6 million in Q3 2025.